1 |
TOP2A |
DNA Topoisomerase II α |
Target for anticancer agents; mutations are associated with drug resistance |
2 |
PAICS |
Phosphoribosylaminoimidazole carboxylase |
Involved in de novo synthesis of purine nucleotides |
3 |
CDK1 |
Cyclin-dependent kinase 1 |
Regulates cell cycle progression, apoptosis and carcinogenesis of tumour cells |
4 |
CKS2 |
CDC28 protein kinase regulatory subunit 2 |
Binds to the catalytic subunit of cyclin-dependent kinases; essential for their biological function |
5 |
CKAP2 |
Cytoskeleton associated protein 2 |
Possesses microtubule stabilizing properties; involved in regulating aneuploidy, cell cycle and cell death in a p53/TP53-dependent manner |
6 |
CEP55 |
Centrosomal protein 55 |
Promotes the proliferation of lung, breast and thyroid cancer |
7 |
VEGFA |
Vascular endothelial growth factor A |
Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces blood vessel permeabilization |
8 |
PHLPP2 |
PH domain and leucine rich repeat protein phosphatase 2 |
Regulates Akt and PKC signalling. |
9 |
RRM2 |
Ribonucleotide reductase M2 polypeptide |
Catalyses the biosynthesis of deoxyribonucleotides; inhibits Wnt signalling |
10 |
NEK2 |
NIMA (never in mitosis gene a)-related kinase 2 |
Involved in the regulation of mitosis |